Clinical Trials on Neoplasms, Second Primary in Austria

Total 7070 results

Medical University of Vienna

Suspended

Efficacy of Ovarian Stimulation Based on FSHR Genotype Status

Sterility

Austria
Janssen Research & Development, LLC

Recruiting

A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Taxane Chemotherapy, or Androgen Receptor Pathway Inhibitors for Metastatic Castration-Resistant Prostate Cancer

Metastatic Castration-resistant Prostate Neoplasms

United States, Australia
EBG MedAustron GmbH

Recruiting

Radiotherapy for Locally Advanced Pancreatic Carcinomas (Phase II Trial) (LAPC)

Pancreas Cancer

Austria
Amgen

Completed

Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer

Carcinoma | Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer

Belgium, Spain, Australia
The Ludwig Boltzmann Institute of Retinology and...

Completed

Primary Vitrectomy With Endolaser or Encircling Band for Rhegmatogenous Retinal Detachment

Rhegmatogenous Retinal Detachment | Primary Vitrectomy | Encircling Band | Endolaser Treatment

Austria
Medical University of Vienna

Completed

Effect of Xalacom® (Latanoprost/Timolol) and Combigan® (Brimonidine/Timolol) Fixed Combination on Intraocular Pressure and Ocular Blood Flow in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Ocular Physiology | Retina

Austria
Royal North Shore Hospital

Completed

Early Investigation of High Precision Radiotherapy Prior to Commencing Standard Radiotherapy for Prostate Cancer (BOOSTER)

Prostate Cancer

Australia
Cancer Therapeutics Research Group
National Cancer Institute (NCI)

Completed

Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer

Prostate Cancer

Australia, Singapore, Hong Kong
Peter MacCallum Cancer Centre, Australia

Recruiting

Cabazitaxel in Combination With 177Lu-PSMA-617 in Metastatic Castration-resistant Prostate Cancer (LuCAB)

Metastatic Castration-resistant Prostate Cancer | mCRPC

Australia
Austrian Breast & Colorectal Cancer Study Group
Hoffmann-La Roche; Merck Gesellschaft mbH, Austria

Completed

Preoperative Chemoradiation With Capecitabine and Cetuximab

Rectal Cancer

Austria
Medical University of Graz

Recruiting

IUL Study A Randomized Sham - Controlled Clinical Study

Stress Urinary Incontinence

Austria
Olivia Newton-John Cancer Research Institute
Bristol-Myers Squibb

Active, not recruiting

A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers

Gastrointestinal Cancer | Malignant Female Reproductive System Neoplasm | Neuroendocrine Tumours

Australia
Hoffmann-La Roche

Terminated

A Study of Subcutaneously Administered Herceptin (Trastuzumab) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (LISAH)

Breast Cancer

Austria
Medical University of Graz

Completed

In Vivo Confocal Scanning Laser Microscopy of Benign Nevi (CSLM-nevi)

Nevus

Austria
St George Hospital, Australia

Recruiting

Hemiablative Focal Brachytherapy Pilot Study

Prostate Cancer

Australia
Royal North Shore Hospital
University of Sydney

Completed

Feasibility Study Into Adjustment of the Radiation Beam to Account for Prostate Motion During Radiotherapy. (CALYPSO)

Prostate Cancer

Australia
Ludwig Institute for Cancer Research
Pfizer; Heidelberg Pharma AG

Terminated

Study of Safety and Functional Imaging of cG250 and Sunitinib in Patients With Advanced Renal Cell Carcinoma

Renal Cell Carcinoma (RCC)

Australia
University Medicine Greifswald
Children's Cancer Research Institute, Austria

Active, not recruiting

Phase II Study of Monoclonal Antibody ch14.18/CHO Continuous Infusion in Patients With Primary Refractory or Relapsed Neuroblastoma

Neuroblastoma

Germany, Austria
Cepheid
Axonal-Biostatem; Stève Consultants

Completed

A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X) (ANTICIPATE X)

Non-muscle-invasive Bladder Cancer

United Kingdom, Netherlands, Spain, Sweden, Austria, Germany, Czechia, France, Italy
Medical University of Vienna

Unknown

Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell Lymphoma

Lymphoma, Mantle-Cell

Austria
Sanofi

Completed

Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy

Prostatic Neoplasms

United States, France, Brazil, Russian Federation, Australia, Turkey, India, Austria, Israel, Italy, Mexico, United Kingdom, Germany, Poland, Netherlands, South Africa, Canada
German Breast Group

Recruiting

Long-term Safety and Efficacy of GBG Study Participants (ETERNITY)

Breast Cancer

Austria
Progen Pharmaceuticals
Aventis Pharmaceuticals; Northern Sydney and Central Coast Area Health Service

Completed

Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer

Prostate Cancer

Australia
Medical University of Vienna
Roche Pharma AG; Allcyte GmbH

Recruiting

Comprehensive Genomic Profiling and Next Generation Functional Drug Screening for Patients With Aggressive Haematological Malignancies (EXALT-2)

Refractory Acute Myeloid Leukemia | Advanced Lymphoma | Refractory Lymphoma | Refractory Leukemia | Refractory T-Cell Lymphoma

Austria
Peter MacCallum Cancer Centre, Australia

Completed

A Prospective Single Arm Study of Intraoperative Radiotherapy for Locally Advanced or Recurrent Rectal Cancer

Malignant Rectal Neoplasm | Recurrent Tumor

Australia
Uptake Medical Technology, Inc.

Not yet recruiting

Vapor Ablation for Localized Cancer Lesions (VAPORIZED)

Lung Cancer | Non Small Cell Lung Cancer | Metastatic Lung Cancer

Austria, Italy
University of Salzburg
Biolitec Pharma Ltd.

Unknown

Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct Carcinoma

Non-curative Resectable Bile Duct Carcinoma

Austria, Germany
Univ.-Doz. Dr.med.univ. Gernot Hudelist, MSc.

Completed

Comparison of Ultrasound-determined and Intraoperative #Enzian-classification in Patients With Deep Endometriosis

Endometriosis

Austria
Peter MacCallum Cancer Centre, Australia
St Vincent's Hospital, Sydney

Recruiting

PSMA PET Additive Value for Prostate Cancer Diagnosis in Men With Negative/Equivocal MRI (PRIMARY2)

Prostate Cancer

Australia
Medical University of Vienna

Unknown

Psychological Distress in Outpatient Oncological Rehabilitation

Distress | Oncology

Austria
PX Biosolutions

Completed

Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity

Cervical Cancer | Acute Myeloid Leukemia | Chronic Myeloid Leukemia | Ovarian Serous Adenocarcinoma | Undifferentiated Carcinoma of Ovary | Cervical Intraepithelial Neoplasia, Grade 3

Australia
Prim. Priv. Doz. Dr. Daniel Cejka
Amgen

Completed

A Study to Investigate the Influence of PTH-lowering by Etelcalcetide (Parsabiv®) on the Calcification Propensity of Serum in Dialysis Patients

End Stage Renal Disease

Austria
Ipsen

Terminated

Study to Evaluate the Safety and Preliminary Efficacy of 177Lu-OPS201 in NETs

Neuroendocrine Tumors

United States, Australia, Austria, Canada, Denmark, France, Switzerland, United Kingdom
Peter MacCallum Cancer Centre, Australia

Recruiting

ProsTIC Registry of Men Treated With PSMA Theranostics

Prostate Cancer | Metastatic Castration-resistant Prostate Cancer

Australia
Peter MacCallum Cancer Centre, Australia

Active, not recruiting

EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T (VIOLET)

Prostate Cancer | Metastatic Castration-resistant Prostate Cancer

Australia
Medical University Innsbruck

Completed

Abdominal Binder to Treat Orthostatic Hypotension (OH) in Parkinson's Disease (PD) (ABOHP)

Parkinson's Disease | Neurogenic Orthostatic Hypotension in Parkinson's Disease

Austria
Medical University of Graz

Completed

Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients

Skin Cancer | Basal Cell Nevus Syndrome | Xeroderma Pigmentosum

Austria
Royal North Shore Hospital

Completed

Prostate-Rectal Separation With PEG Hydrogel and Its Effect on Decreasing Rectal Dose

Cancer of the Prostate

Australia
Arbeitsgemeinschaft medikamentoese Tumortherapie

Recruiting

AGMT Austrian Lymphoma Registry

Lymphoma

Austria
Medical University of Vienna

Recruiting

Continuous Stitches Versus Simple Interrupted Stitches for Anterior Colporrhaphy

Pelvic Organ Prolapse | Cystocele | Vaginal Prolapse | Cystocele, Midline | Prolaps Bladder

Austria
Universitätsklinikum Hamburg-Eppendorf
Cancer Research UK; Deutsche Krebshilfe e.V., Bonn (Germany); Australasian Gastro-Intestinal... and other collaborators

Active, not recruiting

Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer (ACTICCA-1)

Cholangiocarcinoma | Gall Bladder Carcinoma

Germany, Netherlands, United Kingdom, Australia, Denmark, Italy, New Zealand, Austria
Calvary Mater Newcastle, Australia
Abbott

Completed

PROstate Cancer Imaging, Treatment and Toxicity (PROCITT) (PROCITT)

Prostate Cancer

Australia
EBG MedAustron GmbH
Landesklinkum Wiener Neustadt

Recruiting

Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic Cancer (PARC)

Pancreatic Cancer | Proton Therapy

Austria
Medical University of Graz

Recruiting

Bloodpressure and NIRS During the Immediate Transition (RR)

Blood Pressure | Cerebral Tissue Oxygenation

Austria
Trans Tasman Radiation Oncology Group

Active, not recruiting

Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney (FASTRACK II)

Renal Cell Carcinoma

Australia
Atridia Pty Ltd.

Completed

A Phase I Trial of HS-10241 in Solid Tumors

Solid Tumors | Neoplasm

Australia
Universitaire Ziekenhuizen KU Leuven
European Commission

Completed

European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer (EUDARIO)

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma

Germany, Belgium, Italy, Austria, France
Telix Pharmaceuticals (Innovations) Pty Limited

Active, not recruiting

External Beam Therapy With Theranostic Radioligand Therapy for Oligometastatic Prostate Cancer (ProstACT TARGET)

Prostate Cancer

Australia
Peter MacCallum Cancer Centre, Australia

Recruiting

Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men With Metastatic Castration-Resistant Prostate Cancer (AlphaBet)

Prostate Cancer | Metastatic Castration-resistant Prostate Cancer | mCRPC

Australia
Medical University of Graz

Terminated

High-dose Vitamin D3 in Pancreas Cancer (VITdCUT)

Quality of Life | Vitamin D Deficiency | Pancreas Cancer

Austria

Clinical Trials on Neoplasms, Second Primary in Austria

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations